Drug Approval | September 12, 2021
US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
HTL will build, validate and operate a botulinum manufacturing facility in the US
The medicine is now approved for eight indications across five different types of cancer in China.
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
Subscribe To Our Newsletter & Stay Updated
